vaccines
The key to the technique's success was the timing of the vaccine, explained the study's co-senior author, Harvard Medical School associate professor Glenn Dranoff, of DFCI. Photograph by Steve Gilbert |
Study finds promise in combined transplant/vaccine therapy for high-risk leukemiaTwo of the most powerful approaches to cancer treatment — a stem cell transplant and an immune system-stimulating vaccine — appear to reinforce each other in patients with an aggressive, hard-to-control form of leukemia, Harvard scientists at Dana-Farber Cancer Institute (DFCI) have found. |
vaccines links: |
Other vaccines storiesall recent title) ?> stories» |
